This is the division, I believe, that Fauci runs. Makes me shake my head why the EI Lilly drug/antibody was shut down so fast and yet the seemingly worthless Remsdesivir sailed thru not passing one clinical trial.

So with the EI Lilly drug down that just leaves the Regeneron antibody drug left and that had some safety issues I believe so Brilacidin still rising to the top IMO.

Something is just not right.

Don't think Brilacidin has anything to worry about as results in the human trial should speak for themselves.